Imperial College London

Professor Duncan Bassett

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Professor of Endocrinology



+44 (0)20 3313 4613d.bassett Website




10N6 Commomwealth BuildingHammersmith HospitalHammersmith Campus





Duncan Bassett is a Professor of Endocrinology at Imperial College and is a Consultant Physician at the Academic Health Sciences Centre specialising in Metabolic Bone Disease.  He obtained a BA in Pathology from Cambridge University and a BM BCh from Oxford University.  He undertook his research training at the Medical Research Council Clinical Sciences Centre, initially as an MRC Clinical Training Fellow and subsequently as MRC Clinician Scientist.  He completed his PhD at Imperial College in 2000, was appointed Professor in 2013 and a Wellcome Trust Investigator in 2016.

Professor Bassett is a Principal Investigator in the Molecular Endocrinology Laboratory in the Department of Medicine at the Hammersmith Hospital.  His current research is focused on understanding the fundamental cellular and molecular mechanisms that underlie skeletal development, maintenance and repair and their dysregulation in chronic degenerative diseases such as osteoporosis and osteoarthritis.

His investigation of the molecular basis of bone and cartilage disease have resulted in the identification of new genetic determinants of bone mass and strength and resulted in Wellcome Trust Strategic Award funding. 

Professor Bassett also has longstanding interest in thyroid hormone action and particularly its role in the developing and adult skeleton.  His studies have clarified the complex relationship between central and peripheral thyroid status and identified a critical role for local thyroid hormone metabolism in bone and cartilage.  These studies have been the result of longstanding and productive collaborations with many of the worlds leading thyroid hormone researchers and have recently resulted in Horizon 2020 funding and a Wellcome Trust Investigator Award.

The Molecular Endocrinology Laboratory is an international leader in skeletal phenotyping and thyroid hormone action and Professor Bassett frequently receives invitations to speak at international scientific conferences in Europe, America and Japan. Members of the Molecular Endocrinology Group have been awarded 8 research prizes in the last 5 years.

He is currently a member of the Executive Committee of the European Thyroid Association and the Bone Research Society.  He is the clinical chair of the Society for Endocrinology Bone and Calcium Network and sits on the Society’s Science and Programme committees. His is on the editorial board of Endocrinology and is a senior editor for the Journal of Endocrinology and Journal of Molecular Endocrinology


Origins of Bone and Cartilage Disease Web Site

Molecular Endocrinology Laboratory ENDO-TV Film


Selected Publications

  1. JHD Bassett, GR Williams (2016) Role of thyroid hormones in skeletal development and bone maintenance. Endocrine Reviews 37:135-187 (PMID: 26862888)
  2. H Kang, A Kerloc’h, M Rotival, X Xu, Q Zhang, Z D’Souza, M Kim, JC Scholz, J-H Ko, PK Srivastava, JR Genzen, W Cui, TJ Aitman, L Game, JE Melvin, A Hanidu, J Dimock, J Zheng, D Souza, A Behera, G Nabozny, HT Cook, JHD Bassett, GR Williams, J Li, A Vignery, E Petretto, J Behmoaras (2014) Kcnn4 is a new regulator of macrophage multinucleation in bone homeostasis and inflammatory disease. Cell Reports 8:1210-24. (PMID: 25131209)
  3. JHD Bassett, A Boyde, T Zikmund, H Evans, PI Croucher, X Zhu, JW Park, S-y Cheng, GR. Williams. (2014) TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia. Endocrinology  155:3699-712 (PMID: 24914936)
  4. JHD Bassett, A Gogakos, JK White, H Evans, RM Jacques, A van der Spek, , R Ramirez-Solis, E Ryder, D Sunter, A Boyde, MJ Campbell, PI Croucher, GR Williams (2012) Rapid-throughput skeletal phenotyping of 100 knockout mice identifies 9 new genes that determine bone strength. PLoS Genetics 8(8) e1002858 (PMID:22876197)
  5. JHD Bassett, A. Boyde, PGT Howell, RH Bassett, TM Galliford, M Archanco, H Evans, MA Lawson, P Croucher, D St.Germain, VA Galton, GR Williams (2010) Optimal bone mineralization and strength requires the type 2 iodothyronine deiodinase in osteoblasts. Proc. Natl. Acad. Sci. USA 107:7604-7609 (PMID: 20368437)



Lademann F, Mayerl S, Tsourdi E, et al., 2022, The Thyroid Hormone Transporter MCT10 Is a Novel Regulator of Trabecular Bone Mass and Bone Turnover in Male Mice., Endocrinology, Vol:163

Youlten SE, Kemp JP, Logan JG, et al., 2021, Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease, Nature Communications, Vol:12, ISSN:2041-1723, Pages:1-21

Formosa MM, Bergen DJM, Gregson CL, et al., 2021, A Roadmap to gene discoveries and novel therapies in monogenic low and high bone mass disorders, Frontiers in Endocrinology, Vol:12, ISSN:1664-2392, Pages:1-24

Makitie RE, Henning P, Jiu Y, et al., 2021, An ARHGAP25 variant links aberrant Rac1 function to early-onset skeletal fragility, Jbmr Plus, Vol:5


Dennis EP, Brito FMJDS, Pearson RD, et al., 2021, Asporin is important in bone development but not in cartilage homeostasis, WILEY, Pages:A8-A9, ISSN:0959-9673

More Publications